Literature DB >> 24665414

Cognition in Late Life Depression: Treatment Considerations.

Aaron M Koenig1, Meryl A Butters1.   

Abstract

Late life depression (LLD) frequently presents with cognitive impairment, and growing evidence suggests that these disease processes are "linked" in multiple ways. For some individuals, LLD may be a recurrence of a long-standing depressive illness, while for others it may be the leading symptom of a developing neuropathological disorder. Overall, studies investigating the relationship between treatment of LLD and improvement in cognitive functioning have yielded mixed results. Research suggests that a subset of individuals with LLD and cognitive dysfunction will experience an improvement in cognitive function after antidepressant treatment, though a significant proportion will continue to exhibit cognitive impairment following resolution of their depressive symptoms. From a treatment standpoint, it is critical to ensure that an individual's depressive symptoms have been treated to remission, measured by a standardized rating scale such as the Geriatric Depression Scale (GDS). SSRI or SNRI monotherapy is often effective, and may be enhanced by employing an evidence-based psychotherapy such as Problem Solving Therapy (PST) or Interpersonal Therapy (IPT), modified to accommodate cognitive impairments that may be present. With respect to specific treatment of cognitive dysfunction, cognitive augmentation or training strategies can be helpful for some patients, and may be explored in combination with treatment of the primary depressive episode. While the introduction of a cholinesterase inhibitor (e.g. donepezil) may be considered, the potential benefit (modest improvement in cognition and functioning) must be weighed against an increased risk for worsening or recurrent depression. Finally, lifestyle factors-such as aerobic exercise, follow-up with a primary care physician for management of co-morbid medical illnesses, and regular participation in stimulating activities (such as through a senior center)-are important and should be included as part of the overall treatment plan.

Entities:  

Keywords:  antidepressant; cognitive training; dementia; electroconvulsive therapy; emerging treatments; late-life depression; mild cognitive impairment; pharmacotherapy; psychotherapy; treatment

Year:  2014        PMID: 24665414      PMCID: PMC3961714          DOI: 10.1007/s40501-013-0001-2

Source DB:  PubMed          Journal:  Curr Treat Options Psychiatry


  63 in total

1.  Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.

Authors:  Charles F Reynolds; Meryl A Butters; Oscar Lopez; Bruce G Pollock; Mary Amanda Dew; Benoit H Mulsant; Eric J Lenze; Margo Holm; Joan C Rogers; Sati Mazumdar; Patricia R Houck; Amy Begley; Stewart Anderson; Jordan F Karp; Mark D Miller; Ellen M Whyte; Jacqueline Stack; Ariel Gildengers; Katalin Szanto; Salem Bensasi; Daniel I Kaufer; M Ilyas Kamboh; Steven T DeKosky
Journal:  Arch Gen Psychiatry       Date:  2011-01

Review 2.  Deep brain stimulation for the treatment of Alzheimer disease and dementias.

Authors:  Adrian W Laxton; Andres M Lozano
Journal:  World Neurosurg       Date:  2012-06-19       Impact factor: 2.104

Review 3.  Antidepressants for depressed elderly.

Authors:  P Mottram; K Wilson; J Strobl
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Prevalence of depression among older Americans: the Aging, Demographics and Memory Study.

Authors:  David C Steffens; Gwenith G Fisher; Kenneth M Langa; Guy G Potter; Brenda L Plassman
Journal:  Int Psychogeriatr       Date:  2009-06-12       Impact factor: 3.878

5.  Neuropsychological differences between late-onset and recurrent geriatric major depression.

Authors:  Michael A Rapp; Karen Dahlman; Mary Sano; Hillel T Grossman; Vahram Haroutunian; Jack M Gorman
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

6.  Executive deficits in elderly patients with major unipolar depression.

Authors:  Sophie Baudic; Catherine Tzortzis; Gianfranco Dalla Barba; Latchezar Traykov
Journal:  J Geriatr Psychiatry Neurol       Date:  2004-12       Impact factor: 2.680

7.  Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study.

Authors:  Eric J Lenze; Elizabeth R Skidmore; Amy E Begley; John W Newcomer; Meryl A Butters; Ellen M Whyte
Journal:  Int J Geriatr Psychiatry       Date:  2011-12-16       Impact factor: 3.485

Review 8.  Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach.

Authors:  Giovanni A Fava; Chiara Ruini; Nicoletta Sonino
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.

Authors:  Martha L Bruce; Thomas R Ten Have; Charles F Reynolds; Ira I Katz; Herbert C Schulberg; Benoit H Mulsant; Gregory K Brown; Gail J McAvay; Jane L Pearson; George S Alexopoulos
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

10.  Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study.

Authors:  George S Alexopoulos; Charles F Reynolds; Martha L Bruce; Ira R Katz; Patrick J Raue; Benoit H Mulsant; David W Oslin; Thomas Ten Have
Journal:  Am J Psychiatry       Date:  2009-06-15       Impact factor: 18.112

View more
  7 in total

1.  Exercise for Cognitive Symptoms in Depression: A Systematic Review of Interventional Studies.

Authors:  Meng Sun; Krista Lanctot; Nathan Herrmann; Damien Gallagher
Journal:  Can J Psychiatry       Date:  2017-11-29       Impact factor: 4.356

Review 2.  [Depression in old age, part 2 : Comorbidity and treatment].

Authors:  Dirk K Wolter
Journal:  Z Gerontol Geriatr       Date:  2016-02-11       Impact factor: 1.281

Review 3.  Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.

Authors:  James M Wilkins; Brent P Forester
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

4.  Depression and cerebrovascular disease: could vortioxetine represent a valid treatment option?

Authors:  Mauro Giovanni Carta; Andrea Norcini Pala; Gabriele Finco; Mario Musu; Maria Francesca Moro
Journal:  Clin Pract Epidemiol Ment Health       Date:  2015-02-27

Review 5.  Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease.

Authors:  Flavie Darcet; Alain M Gardier; Raphael Gaillard; Denis J David; Jean-Philippe Guilloux
Journal:  Pharmaceuticals (Basel)       Date:  2016-02-17

6.  Treatment resistant depression or dementia: a case report.

Authors:  Zhongyong Shi; Shifu Xiao; Xia Li
Journal:  Shanghai Arch Psychiatry       Date:  2016-04-25

7.  The development of an RDoC-based treatment program for adolescent depression: "Training for Awareness, Resilience, and Action" (TARA).

Authors:  Eva Henje Blom; Larissa G Duncan; Tiffany C Ho; Colm G Connolly; Kaja Z LeWinn; Margaret Chesney; Frederick M Hecht; Tony T Yang
Journal:  Front Hum Neurosci       Date:  2014-08-19       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.